'Navigator' - An innovative approach to mobilise our FiY1 doctors during this emergency crisis.

COVID-19大流行导致NHS劳动力超出合理需求。减轻这种工作量的一种方法是，英国医学院理事会将最后一年毕业的医学生快速培养为合格的医生。这些新获得资格的基金会过渡一年级（FiY1）医生是宝贵的资源，将完成低风险的程序和文书工作。潜在的问题是有效地利用这个前所未有的FiY1角色，以一种真正减轻当前NHS员工额外工作量的方式。最大限度地利用经验丰富的临床工作人员的时间和资源，是抗击这一流行病的关键。FiY1角色的新颖性不可避免地导致了现有医务人员与FiY1医生之间的不确定性、担忧和沟通问题。我们预测，这可能会导致医疗保健系统内在的低效率，这是NHS在大流行期间无法承受的（例如工作流程、监督角色的负担和员工之间的协调）。我们提议的机制解决了本次大流行期间的当前工作量。我们的服务（Navigator）将取代主管面对面协调新fiy15的需要；其他工作人员可以实时要求FiY1医生到病房执行他们能胜任的特定职责。这不仅为有经验的员工腾出时间专注于其他工作，而且还最大限度地提高了FiY1医生的效率。对患者而言，这意味着更快的诊断和治疗，加快了患者途径，缩短了住院时间；对员工来说，这意味着一个更有效率的工作日。我们设想FiY1医生在整个医院的病房之间流动，比以往任何时候都更快地满足临床环境的需求-一旦完成一项任务，FiY1可以简单地打开我们的应用程序并转移到下一个临床任务。为了通过这项技术提高他们的表现，我们将通过每周工作报告将工作责任数字化，这些报告可以提交给他们的临床主管。没有传输患者数据，员工详细信息是匿名的，因此不存在数据保护或安全问题。我们正在推动国民保健服务无纸化议程，减少在大流行期间可能变得复杂的面对面沟通。在当前的医疗环境中，简化工作流程的必要性比以往任何时候都更加重要。在这段困难时期，我们重新设计了医务人员与FiY1医生联系的方式，我们希望未来的医生和学生也能这样做。病人也将受益于响应更迅速的NHS服务。我们已经完成了Navigator的Beta阶段测试，目前该产品正在接受专业审核和压力测试，并计划进一步进行数字认证。影响延期将使我们能够完成全面的研究和开发评估，符合数字实施的国家指导方针，我们估计将于2021年1月完成。因此，影响扩展将使我们能够超越产品，正式准备在英国NHS广泛实施。这包括用户研究、通信互操作性、数据安全和信息治理。我们的商业模式目前建立在一个框架上，我们期望通过我们的实施和试用许可费用来获得我们可以维持项目发展的收入。我们的商业战略家为我们提供了如何与医院高管进行讨论的蓝图，并向我们详细展示了如何成功完成NHS招标过程。他还向我们提供了访问他完善的网络的途径，其中包括一系列知名的医疗保健专业人士和企业家，我们可以参与讨论，以便在国际上推出，只有在产品在几家医院获得正式许可并在英国医学教育中建立据点之后。在此扩展后，这将是我们的产品开发的最后阶段。在此之后，我们将通过与我们的商业战略家在这个项目的第一季度开发的商业模式来执行全国商业化。

The COVID-19 pandemic has caused the NHS workforce to be stretched beyond reasonable demands. One method of relieving this workload was for the UK Medical School Council to fast-track final year graduated medical students to qualified doctors. These newly qualified Foundation Interim Year 1 (FiY1) doctors are a valuable resource and will be completing low-risk procedures and clerking.The potential problem is effectively utilising this unprecedented FiY1 role in a way that truly alleviates the extra workload for current NHS staff. Maximising time and resources of experienced clinical staff is key to fighting this pandemic. The novelty of the FiY1 role invites inevitable uncertainty, worry and communication issues between current medical staff and FiY1 doctors. We predict this will potentially lead to an inherent inefficiency within the healthcare system that the NHS cannot afford during a pandemic (e.g. work flow, burden on supervision roles and coordination between staff). Our proposed mechanism addresses the current workload during this pandemic.Our service (Navigator) will replace the need of face-to-face coordination of new FiY1s by supervisors; in real-time, FiY1 doctors can be requested to wards by other staff members for specific duties they are competent in. This not only frees-up time for experienced staff to focus on other work but also maximises the efficiency of the FiY1 doctor. For patients, this means faster diagnosis and treatment speeding up the patient pathway and less time in hospital; for staff this means a more productive workday. We envision FiY1 doctors flowing between wards across the hospital, meeting demand in clinical settings quicker than ever before - once one task is completed the FiY1 can simply open our application and move onto the next clinical duty. To enhance their performance with this technology, we will digitalise responsibility of work through weekly work reports that can be submitted to their clinical supervisors. There is no patient data transferred and staff details are anonymized, so there are no data protection or security issues. We are facilitating the paperless NHS agenda and reducing face-to-face communication which can be complicated during a pandemic.The necessity to stream-line workflow is more vital than ever in the current healthcare climate. We have reinvented the way medical staff will liaise with FiY1 doctors during this difficult time, and we hope also doctors and students of the future. Patients will also be the beneficiaries of a more responsive NHS service.--ADDITIONAL INFORMATION HERE-- We have completed Beta Phase Testing of Navigator and the product is currently being audited and stress-tested professionally with plans for further digital certification. The Extension for Impact will allow us to complete a full comprehensive research and development assessment, meeting national guidelines for digital implementation, we estimate to be completed by January 2021. Hence, the Extension for Impact will enable us to excel the product to be officially prepared for widespread implementation across NHS England. This includes user research, communication interoperability, data security and information governance.Our business model currently stands on the framework that we are expecting through our implementation and trial license fees to gain us a revenue that we can sustain the development of the project through. Our business strategist has provided us with a blueprint of how to engage in discussions with hospital executives and shown us at length how to successfully complete the NHS tendering process. He has also provided us with access to his well-established networks, that include a range of high-profile healthcare professionals and entrepreneurs that we can engage in discussions to launch internationally, only once the product is officially licensed in a few hospitals and develops a stronghold in medical education in the UK. After this extension this will be our last phase of product development. After this will be executing national commercialisation through the business model developed within the first quarter of this project with our business strategist.